<SEC-DOCUMENT>0000885590-25-000010.txt : 20250319
<SEC-HEADER>0000885590-25-000010.hdr.sgml : 20250319
<ACCEPTANCE-DATETIME>20250319115700
ACCESSION NUMBER:		0000885590-25-000010
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250319
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250319
DATE AS OF CHANGE:		20250319

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bausch Health Companies Inc.
		CENTRAL INDEX KEY:			0000885590
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14956
		FILM NUMBER:		25751460

	BUSINESS ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8
		BUSINESS PHONE:		514-744-6792

	MAIL ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Valeant Pharmaceuticals International, Inc.
		DATE OF NAME CHANGE:	20100928

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL Corp
		DATE OF NAME CHANGE:	20100416

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL CORP INTERNATIONAL
		DATE OF NAME CHANGE:	19960522
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bhc-20250319.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:cedd2260-619c-4457-bdd0-1394efb1e371,g:3c9705cd-13aa-4244-9fbb-5af4aaf66829,d:3f3f12cbd5d040268348a467e591508c-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bhc-20250319</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-23">0000885590</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-24">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bhc-20250319.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885590</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-19</xbrli:startDate><xbrli:endDate>2025-03-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3f3f12cbd5d040268348a467e591508c_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">March 19, 2025</ix:nonNumeric></span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Bausch Health Companies Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.729%"><tr><td style="width:1.0%"/><td style="width:29.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.278%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="f-4">British Columbia</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-5">Canada</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-14956</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-7">98-0448205</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission file number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-8">2150 St. Elz&#233;ar Blvd. West</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Laval</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">Qu&#233;bec</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-11">Canada</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">H7L 4A8</ix:nonNumeric></span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">514</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">744-6792</ix:nonNumeric> </span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-18">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.635%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.913%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-19">Common Shares, No Par Value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-20">BHC</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-21">New York Stock Exchange</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Toronto Stock Exchange</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company     </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-22">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div></div><div id="i3f3f12cbd5d040268348a467e591508c_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Item 8.01 Other Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Secured Notes Offering </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On March 19, 2025, Bausch Health Companies Inc. (the &#8220;Company&#8221;) issued a press release announcing that its indirect wholly-owned subsidiary, 1261229 B.C. Ltd. (the &#8220;Issuer&#8221;) launched an offering of $4.0 billion aggregate principal amount of new senior secured notes due 2032 (the &#8220;Notes&#8221;). The Company plans to offer the Notes in the United States to qualified institutional investors pursuant to Rule 144A under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) that are also qualified purchasers within the meaning of Section 2(a)(51) of the Investment Company Act of 1940, as amended, and to non-U.S. persons outside of the United States pursuant to Regulation S under the Securities Act. The Company plans to use the net proceeds from the offering of the Notes, together with the proceeds of a new term loan facility (the &#8220;New Term Loan Facility&#8221;), (i) to repay in full and terminate the Company&#8217;s secured term loan facility maturing in 2027 (&#8220;BHC Existing Term Loan Facility&#8221;), (ii) to redeem all of the Company&#8217;s outstanding 5.500% Senior Secured Notes due 2025 (the &#8220;2025 Secured Notes&#8221;), its 9.000% Senior Notes due 2025 (the &#8220;2025 Unsecured Notes&#8221; and, together with the 2025 Secured Notes, the &#8220;2025 Notes&#8221;), its 6.125% Senior Secured Notes due 2027 (the &#8220;6.125% 2027 Notes&#8221;) and its 5.750% Senior Secured Notes due 2027 (the &#8220;5.750% 2027 Notes&#8221; and, together with the 6.125% 2027 Notes, the &#8220;2027 Notes&#8221; and, cumulatively with the 2025 Notes, the &#8220;BHC Existing Notes&#8221;), (iii) to fund the redemption of its indirect subsidiary&#8217;s 9.000% Senior Secured Notes due 2028 (the &#8220;HoldCo Notes&#8221; and, collectively, with the BHC Existing Notes, the &#8220;Existing Notes&#8221;), (iv) to pay related fees, premiums and expenses and (v) for general corporate purposes. The Company also issued a press release under Rule 135c under the Securities Act relating to the offering of Notes, a copy of which is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 do not constitute an offer to sell or the solicitation of an offer to buy any securities, or an offer to purchase, or a solicitation of an offer to sell any securities, nor shall there be any offer, solicitation or sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The Notes will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws. The Notes have not been and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the securities in Canada will be made on a basis which is exempt from the prospectus requirements of such securities laws.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">New Credit Facilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Also, on March 19, 2025, the Company launched the syndication of new senior secured credit facilities expected to consist of (i) a five-year senior secured revolving credit facility in an amount of at least $400 million (the &#8220;New Revolving Facility&#8221;) and (ii) a $3,400 million 5.5-year secured term loan B facility (the &#8220;New Term Loan Facility,&#8221; and together with the New Revolving Facility, the &#8220;New Senior Secured Credit Facilities&#8221;) through the Issuer. The obligations under the New Senior Secured Credit Agreement will be pari passu with the Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The foregoing is qualified by reference to the press release that is attached as Exhibit 99.2 to this Current Report on Form 8-K, which is incorporated herein by reference</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Redemption of Existing Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additionally, on March 19, 2025, the Company or a subsidiary of the Company, as applicable, delivered a notice of conditional redemption for all of the Existing Notes at the redemption prices specified in the applicable indentures, plus accrued and unpaid interest, if any, to, but not including, the redemption date of the applicable series of Existing Notes (each, a &#8220;Redemption Date&#8221;). The Redemption Date for the 2025 Notes is April 18, 2025 and the redemption date for each of the 2027 Notes and the HoldCo Notes is April 4, 2025. The obligation to redeem the Existing Notes is conditioned upon the consummation of the offering of Notes and the funding of the New Term Loan Facility on or before each Redemption Date (which Redemption Date could be delayed in the Company&#8217;s sole discretion if this condition is not satisfied pursuant to the terms of the applicable indentures). </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On the closing date of the offering of Notes, the Company or a subsidiary of the Company, as applicable, intends to discharge the indentures governing the 2025 Notes. The redemption of the Existing Notes, and the discharge of the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2025 Notes, are each subject to the consummation of the offering of the Notes and the funding of the New Term Loan Facility, as well as certain other customary conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Current Report on Form 8-K does not constitute a notice of redemption of the Existing Notes. There can be no assurances that the conditions precedent to the redemption will be satisfied or that the redemption will occur</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The foregoing is qualified by reference to the press release that is attached as Exhibit 99.1 to this Current Report on Form 8-K, which is incorporated herein by reference. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 9.01.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">(d) Exhibits</span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="margin-top:8pt;padding-left:36pt;padding-right:36pt;text-align:center;text-indent:-72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.540%"><tr><td style="width:1.0%"/><td style="width:17.896%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:77.321%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Description</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">99.1*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bhc-noteslaunchpressreleas.htm">Secured Notes Offering</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline" href="bhc-noteslaunchpressreleas.htm"> </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bhc-noteslaunchpressreleas.htm">Press Release dated March 19, 2025</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">99.2*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bhc-termloanlaunchpressrel.htm">Credit Facilities Press Release dated March 19, 2025</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></div></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:174%">____________________________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">*     Filed herewith.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div></div><div id="i3f3f12cbd5d040268348a467e591508c_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: March 19, 2025</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;padding-left:198pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.724%"><tr><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BAUSCH HEALTH COMPANIES INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ JEAN-JACQUES CHARHON</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Jacques Charhon</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>bhc-noteslaunchpressreleas.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ic5d70c641d1e4989be1fa95293a8ac5a_1"></div><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div></div><div style="text-align:right"><img alt="image_01.jpg" src="image_01.jpg" style="height:26px;margin-bottom:5pt;vertical-align:text-bottom;width:212px"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.619%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Investor Contact&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Media Contact&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Garen Sarafian</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Katie Savastano</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ir&#64;bauschhealth.com</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">corporate.communications&#64;bauschhealth.com</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(877) 281-6642 (toll free)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(908) 541-3785</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LAVAL, QC, March 19, 2025 &#8212; Bausch Health Companies Inc. (NYSE&#58; BHC)(TSX&#58; BHC) (the &#8220;Company&#8221; or &#8220;Bausch Health&#8221;) today announced that it has launched an offering (the &#8220;Offering&#8221;) of $4.0 billion aggregate principal amount of new senior secured notes due 2032 (the &#8220;Notes&#8221;) through its indirect wholly-owned subsidiary, 1261229 B.C. Ltd., a company incorporated under the laws of British Columbia, Canada (the &#8220;Issuer&#8221;) that, at the closing of the transactions will be a non-guarantor restricted subsidiary under the indentures that govern the Company&#8217;s existing senior notes. In addition, the Company, through the Issuer, is seeking to enter into new senior secured credit facilities that are expected to consist of (i) a 5-year senior secured revolving credit facility in an amount of at least $400 million (the &#8220;New Revolving Facility&#8221;) and (ii) a $3,400 million 5.5-year senior secured term loan B facility (the &#8220;New Term Loan Facility&#8221; and, together with the New Revolving Facility, the &#8220;New Senior Secured Credit Facilities&#8221;). The Offering and the entry into the New Senior Secured Credit Facilities are subject to market and other conditions.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Notes will be (i) secured, subject to customary limitations, by a first priority lien on substantially all assets of the Issuer, including a pledge of its direct equity interest in Bausch + Lomb and (ii) guaranteed by (x) the Company and subsidiaries of the Company that guarantee the Company&#8217;s existing senior notes, with such guarantees secured by the assets of such guarantors, subject to customary limitations, by a first-priority lien that will rank pari passu with the liens securing the Company&#8217;s existing first-lien senior secured notes and the New Senior Secured Credit Facilities and (y) certain subsidiaries of the Company that do not guarantee the Company&#8217;s existing senior notes, with such guarantees secured by the assets of such guarantors, subject to customary limitations, by a first-priority lien that will rank pari passu with the liens securing the New Senior Secured Credit Facilities.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company intends to use the proceeds from the offering of the Notes, together with the borrowings under the New Term Loan Facility, (i) to repay in full and terminate the Company&#8217;s existing credit agreement, (ii) to redeem all of its 5.500% Senior Secured Notes due 2025, 9.000% Senior Notes due 2025, 6.125% Senior Secured Notes due 2027, 5.750% Senior Secured Notes due 2027 and its indirect subsidiary&#8217;s 9.000% Senior Secured Notes due 2028 (collectively, the &#8220;Existing Notes&#8221;), (iii) to pay related fees, premiums and expenses and (iv) for general corporate purposes. </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company also intends, or a subsidiary of the Company intends, as applicable, to deliver a notice of conditional redemption for all of the Existing Notes at the redemption prices specified in the applicable indentures, plus accrued and unpaid interest, if any, to, but not including, the redemption date of the applicable series of Existing Notes. The obligation to redeem the Existing Notes will be conditioned upon the consummation of the Offering and the funding of the New Term Loan Facility on or before each of the applicable redemption dates (which redemption dates could be delayed in the Company&#8217;s sole discretion if this condition is not satisfied pursuant to the terms of the applicable indentures). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Concurrently with the consummation of the Offering and the funding of the New Term Loan Facility, the Company or a subsidiary of the Company, as applicable, intends to discharge the applicable indentures governing each of the Existing Notes to the extent any such Existing Notes are not redeemed prior to the Closing Date. This press release does not constitute a notice of redemption of the Existing Notes. </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Notes will not be registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or any state securities law and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act and applicable state securities laws. The Notes will be offered in the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act that are also qualified purchasers within the meaning of Section 2(a)(51) of the Investment Company Act of 1940, as amended, and to non-U.S. persons outside of the United States pursuant to Regulation S under the Securities Act. The Notes have not been and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the Notes in Canada will be made on a basis, which is exempt from the prospectus requirements of such securities laws. </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release is being issued pursuant to Rule 135c under the Securities Act and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Bausch Health </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bausch Health Companies Inc. (NYSE&#58; BHC)(TSX&#58; BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward-Looking Statements About Bausch Health</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This news release may contain forward-looking statements within the meaning of applicable securities laws, including the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words &#34;will,&#34; &#34;anticipates,&#34; &#34;hopes,&#34; &#34;expects,&#34; &#34;intends,&#34; &#34;plans,&#34; &#34;should,&#34; &#34;could,&#34; &#34;would,&#34; &#34;may,&#34; &#34;believes,&#34; &#34;subject to&#34; and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular, the Company can offer no assurance that the separation (including a potential sale of Bausch + Lomb) will occur on terms or timelines acceptable to the Company or at all, or as to the ultimate composition of any near-term financing activities, including the proposed use of proceeds therefrom, whether the conditions precedent to the redemption of the Existing Notes will occur, or as to the offering of the Notes, the entry into the New Senior Secured Credit Facilities, and details thereof. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.</font></div><div style="margin-top:2pt"><font><br></font></div><div style="margin-top:2pt"><font><br></font></div><div style="margin-top:2pt"><font><br></font></div><div style="margin-top:2pt"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">### </font></div><div style="margin-top:2pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>bhc-termloanlaunchpressrel.htm
<DESCRIPTION>EX-99.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="iff2f91db763d467382c8da70d3f1f19d_1"></div><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 99.2</font></div></div><div style="text-align:right"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:214px"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-1.38pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Investor Contact&#58; </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-1.38pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Media Contact&#58;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-1.38pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Garen Sarafian</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-1.38pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Katie Savastano</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-1.38pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ir&#64;bauschhealth.com</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-1.38pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">corporate.communications&#64;bauschhealth.com</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-1.38pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(877) 281-6642 (toll free)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-1.38pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(908) 541-3785</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="padding-right:-1.38pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-right:-1.38pt"><font><br></font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Transaction is part of a broader refinancing initiative aimed at opportunistically accessing capital markets to address near- and mid-term maturities </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LAVAL, QC, March 19, 2025 &#8211; Bausch Health Companies Inc. (NYSE&#58; BHC)(TSX&#58; BHC) (the &#8220;Company&#8221; or &#8220;Bausch Health&#8221;) today announced that it has launched the syndication of new senior secured credit facilities totaling at least $3.8 billion. </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The new senior secured credit facilities are expected to consist of (i) a 5-year senior secured revolving credit facility in an amount of at least $400 million (the &#8220;New Revolving Facility&#8221;) and (ii) a $3,400 million 5.5-year secured term loan B facility (the &#8220;New Term Loan Facility&#8221; and, together with the New Revolving Facility, the &#8220;New Senior Secured Credit Facilities&#8221;) through its indirect wholly-owned subsidiary, 1261229 B.C. Ltd., a company incorporated under the laws of British Columbia, Canada (the &#8220;Borrower&#8221;) that, at the closing of the transactions, will be a non-guarantor restricted subsidiary under the indentures that govern the Company&#8217;s existing notes.  </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">JPMorgan Chase Bank, N.A. is the lead arranger for the New Senior Secured Credit Facilities.  </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;The launch of this syndication is the result of a thorough process led by our Board, management team, and independent advisors to evaluate several debt financing alternatives and is consistent with Bausch Health&#8217;s previously stated objective to comprehensively improve our debt maturity profile. The transaction is part of a broader initiative aimed at opportunistically accessing capital markets to address our near- and mid-term maturities,&#8221; said Bausch Health CEO Thomas J. Appio. &#8220;The Company has a diverse, substantial portfolio of assets and, with seven consecutive quarters of top- and bottom-line growth, strong momentum to build on our success in 2025.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Commitment to Paying Down Debt</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bausch Health (excluding Bausch + Lomb) reduced net debt by nearly $1 billion in 2024. The Company remains committed to optimizing its capital structure, strategically reducing debt leverage, and extending maturities to fortify its financial position for long-term success.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Transaction Details</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The New Senior Secured Credit Facilities will be (i) secured, subject to customary limitations, by a first priority lien on substantially all assets of the Borrower, including a pledge of its direct equity interest in Bausch + Lomb and (ii) guaranteed by the Company and subsidiaries of the Company that guarantee the Company&#8217;s existing indebtedness and secured by the assets of the guarantors, subject to customary limitations, by a first-priority lien that will rank pari passu with the liens securing the Company&#8217;s existing first lien secured indebtedness. </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company intends to use the proceeds of the New Term Loan Facility, together with the proceeds of other additional secured indebtedness intended to be raised in connection with the New Senior Secured </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Credit Facilities, to repay in full and terminate the Company&#8217;s existing credit agreement, and (i) to redeem all of its 5.500% Senior Secured Notes due 2025, 9.000% Senior Notes due 2025, 6.125% Senior Secured Notes due 2027, 5.750% Senior Secured Notes due 2027 and its indirect subsidiary&#8217;s 9.000% Senior Secured Notes due 2028, (ii) to pay related fees, premiums and expenses and (iii) for general corporate purposes. The Company will use any amounts borrowed from time to time under the New Revolving Facility, which will replace its existing revolving facility, for general corporate purposes.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These proposed refinancing transactions, including but not limited to the principal amount, interest rate and maturity of the New Senior Secured Credit Facilities and any concurrent financings, are subject to market conditions and to a number of significant conditions, and there can be no assurance that the Company will consummate any of these transactions on the anticipated terms or timing, or at all. </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company was advised by Evercore, Proskauer, and Norton Rose Fulbright Canada. </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">U.S. lenders under the New Senior Secured Credit Facilities must be qualified purchasers within the meaning of Section 2(a)(51) of the Investment Company Act of 1940, as amended.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release is not an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of the securities in any state or other jurisdiction where such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Bausch Health</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bausch Health Companies Inc. (NYSE&#58;BHC)(TSX&#58;BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit </font><font style="color:#3051f2;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.bauschhealth.com </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and connect with us on</font><font style="color:#3051f2;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#3051f2;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">LinkedIn</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward-Looking Statements About Bausch Health </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This news release may contain forward-looking statements within the meaning of applicable securities laws, including the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words &#34;will,&#34; &#34;anticipates,&#34; &#34;hopes,&#34; &#34;expects,&#34; &#34;intends,&#34; &#34;plans,&#34; &#34;should,&#34; &#34;could,&#34; &#34;would,&#34; &#34;may,&#34; &#34;believes,&#34; &#34;subject to&#34; and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular, the Company can offer no assurance that the separation (including a potential sale of Bausch + Lomb) will occur on terms or timelines acceptable to the Company or at all, or any assurance as to our ability to market, negotiate or close the New Senior Secured Credit Facilities on favorable terms or at all, or whether the Company will be able to obtain any new secured revolving credit facility or other additional secured indebtedness, or as to the ultimate composition of any near-term financing activities. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>bhc-20250319.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:cedd2260-619c-4457-bdd0-1394efb1e371,g:3c9705cd-13aa-4244-9fbb-5af4aaf66829-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bhc="http://www.bauschhealth.com/20250319" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bauschhealth.com/20250319">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhc-20250319_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhc-20250319_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Document" roleURI="http://www.bauschhealth.com/role/Document">
        <link:definition>0000001 - Document - Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>bhc-20250319_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:cedd2260-619c-4457-bdd0-1394efb1e371,g:3c9705cd-13aa-4244-9fbb-5af4aaf66829-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_93bd8d6a-54bd-4103-8431-9cf42394c598_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_4bfa7f12-8864-445b-ae9f-78171c7a70d0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_659a6aae-96fa-4f07-9db8-63b2b02c1d4e_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_8797f0f2-817e-4c5e-a9f7-ffc4f7fb7c69_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7ac8816a-0b6c-4344-8e2b-992cfe111026_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2c47c5aa-dd93-4037-b882-73c1d6f5820c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_091d5932-7083-437a-9398-7fa9f3a4f653_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_4f22320d-f43a-4cda-b3f3-0e0477ee3a80_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_460b2438-744b-4040-bfe9-bee9531f87c9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_6f644aca-5d20-4062-9760-d8a498a07d31_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_88210c8b-4c01-4131-9327-b80bac0c12e3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_6d948ceb-3767-4803-a7a7-fdcacab6b685_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_3fd4f29f-da6d-4b95-9a3e-960a8ac827da_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_eb3d1d0b-4f20-4092-a11a-e9c929e472f4_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_7b7d5945-d6dc-4714-a9c5-b2731d8c964c_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6148e6d9-109b-4eb4-b9c4-c57ea6c8d403_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_05fc937c-b1f4-4bdd-8f68-250ff2d6587a_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_2d2bc6a0-0ff6-4cfa-b10c-6e0daa06676d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_d90c4529-b26f-439e-a63d-8789633cdbc1_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d956ee35-a6d5-455b-a80c-a791cd08a7a1_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_fe720a71-56f4-4cd5-9915-0f3d830407e4_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_1f0ee87c-d520-489c-8994-ac23fafec1ad_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_06dda4ec-2bc4-4727-a70c-f0ee26dd143d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7975847a-f867-4b91-87c2-e2fce047c228_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>bhc-20250319_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:cedd2260-619c-4457-bdd0-1394efb1e371,g:3c9705cd-13aa-4244-9fbb-5af4aaf66829-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bauschhealth.com/role/Document" xlink:type="simple" xlink:href="bhc-20250319.xsd#Document"/>
  <link:presentationLink xlink:role="http://www.bauschhealth.com/role/Document" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2bf63605-1729-47a5-8deb-41f2207c36a3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_DocumentType_2bf63605-1729-47a5-8deb-41f2207c36a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_46b8dec9-ed09-4b80-b2a8-4209b102907b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_DocumentPeriodEndDate_46b8dec9-ed09-4b80-b2a8-4209b102907b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e67655ad-6715-4e64-9b4a-182db9699327" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_EntityRegistrantName_e67655ad-6715-4e64-9b4a-182db9699327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_fadfea16-ae1c-4b48-a570-af13df755c4c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_fadfea16-ae1c-4b48-a570-af13df755c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_dcc9e53f-1977-44c7-adb9-336df06dcd9d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_EntityAddressCountry_dcc9e53f-1977-44c7-adb9-336df06dcd9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2f18aeb7-e349-431b-ace3-3ae3a7fa586a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_EntityFileNumber_2f18aeb7-e349-431b-ace3-3ae3a7fa586a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e0c33e4c-5e1b-4004-801f-1db4a5af15a8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_EntityTaxIdentificationNumber_e0c33e4c-5e1b-4004-801f-1db4a5af15a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_28be01be-0ba1-4103-802b-aa2f77fad0be" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_EntityAddressAddressLine1_28be01be-0ba1-4103-802b-aa2f77fad0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c33c196c-d516-4038-aec4-6c820585ed0a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_EntityAddressCityOrTown_c33c196c-d516-4038-aec4-6c820585ed0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_98a61967-49c1-412e-83f6-d985e7864502" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_EntityAddressStateOrProvince_98a61967-49c1-412e-83f6-d985e7864502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b5d3801e-b4a4-451e-954d-20df73fd958b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_EntityAddressPostalZipCode_b5d3801e-b4a4-451e-954d-20df73fd958b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_1f41c097-e71c-45ba-a270-ec333a0e7ab0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_CityAreaCode_1f41c097-e71c-45ba-a270-ec333a0e7ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_61906118-8af7-47dc-ae2a-b8bff4ccbab7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_LocalPhoneNumber_61906118-8af7-47dc-ae2a-b8bff4ccbab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_1f9ede6a-a7f6-4e35-8fb5-6a9997c3a0b6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_WrittenCommunications_1f9ede6a-a7f6-4e35-8fb5-6a9997c3a0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_38c27938-65dc-4e18-a4af-49a24129be91" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_SolicitingMaterial_38c27938-65dc-4e18-a4af-49a24129be91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_086ffd92-5be7-44ce-8374-8ba829105a73" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_PreCommencementTenderOffer_086ffd92-5be7-44ce-8374-8ba829105a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_7787a907-774c-4748-837d-566e9804c770" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_7787a907-774c-4748-837d-566e9804c770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8dd56cc5-9b2b-4672-885d-27ce0e9dbc21" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_Security12bTitle_8dd56cc5-9b2b-4672-885d-27ce0e9dbc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_17fb19b0-7251-4a70-9e8e-ae6c40b4a040" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_TradingSymbol_17fb19b0-7251-4a70-9e8e-ae6c40b4a040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_368aa811-3e6a-4904-8062-c14da7834d9c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_SecurityExchangeName_368aa811-3e6a-4904-8062-c14da7834d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e8e19a04-3fbf-40cb-8208-06e2b9dee226" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_EntityEmergingGrowthCompany_e8e19a04-3fbf-40cb-8208-06e2b9dee226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_29f105ce-3f3e-433b-a5dd-7e80639c2ac4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_EntityCentralIndexKey_29f105ce-3f3e-433b-a5dd-7e80639c2ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1eadaeb3-25d1-41d8-8d04-7612a100d2ff" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3961e9a1-5292-4322-b1b0-dba0355945a6" xlink:to="loc_dei_AmendmentFlag_1eadaeb3-25d1-41d8-8d04-7612a100d2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_01.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "'!% # 2(  A$! Q$!_\0
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MM0*7_P"$IF_[^U\S^']$TMKN7SC_ ,M&[>]6M8T3P[]F(,G/^[3 _0[]BO\
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MME\.+6));Z)<1D?-CTKZO'_!2'1XX-YU*V_\=K\ [3XV^-] .W1M1V8X'6M
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M-W]Y?Z5A+8WCN?N%\/V$?@?3/^O1:UA&KMN&*PO![.O@?3-I_P"71:UK65^
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M2,IY8'%6;")8TPH[5^-R?+:)_1^&M[!]VRQ1112*"F/]XT^F/]XU,=@/G?\
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M>I-,1GR?#\??QTID?A4(VP]J^SO"'_!-GXO>+K$S6%NQRF1_HY-3/_P2,_:
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MX[/G^'^=?JO^QCIY@T= >\/7\*_*?]GVU9/B>CN/E^7^=?K7^R3) -'0H/\
MEA_2ON/%B;]U/L?D'@;AT\SDH[<S/9Q: ?/FK%N@5>*KF\1FVBK$#9%?S]4Y
MO;JY_7J2IQY22BBBM1E6TO&F?:QHFN@DP0]Z@TZUEBERQJ.\5_MH(/&:F.Q%
MV>&_MXQ>?X1_[=C_ %K\ OVVWEA^+YB"'!+]/J*_H!_;BF1/"(WC_EW/]:_
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M'WC(6SQE!]JQC;CUKQK3+2!K95D0$X[U(7D>H>'/VI->FU2"[N#,K(^?F/\
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MU[')\5/FY_?O7BVFW%JH!9!7?#%XBUN;0RA%4TU'J:?P\UNY3QC;6I1@"?\
M"OV,_P""0VDQ7]W SXY;O7XZ>!)K:7QQ;*B#))_F*_9?_@CM"Z7<!/3/]*QJ
M5JBTN8T\%A88A5U'WEU/T2BTZ**+R 144^@PM\V1Q5IXI!-NR<5.K!ACVKFN
M[W.J<8U)\TMS-B+H_P!EQQ5CR!;<KZ5(+4";S-M.N2%&#2>NX^57N1><,8)J
M"XD);BG,CELK2_9V;YC5M12YEN9XF%2-G38A3,8-?GI_P4LT9;GQ5+,5Y$['
M^=?H<KH!M(Z5\!?\%)M1M;?Q',L@'^N;O]:^L\.I5ZF=+74_-O%F$H\'SMW1
M\4?#UYK7Q9,L:$XE'2OUB_8&FEF^'FZ12#Y"]:_*3X::Q82>-)PZ@_O1WK]8
M?V$9H)OA_N@7 \E:_5_%&-:>1QE-WU1^+^ \J3S>7,O?][[M3WFBBBOYXLC^
MM@HHHHL@.3^)^[^R;C:/^7=O_037XT?MEZA<K\9;J(1MCYOYU^S/Q+NX;?2;
MCS0#_H[?^@FOQK_;)U"R?XT77R+GYN_O7[9X0*C5S&<)J^A_-GCG.I2P:<W[
MK>AZ%^PMI(U:YB>1>DA//UK](;2U;_A5L-FJY S_ "%?G?\ L&ZA:PW$8VC[
MY_G7Z6>#+2/5/ T*!0<YQ^0KA\4W+"<1K^7F1KX(PC6X=FI+>)^7O_!17P_/
M%XA+BW;B<'I[UY]^R%-!+\0%L[V0(H9>6KZL_P""B/PP>[U"6=(/NOGI7Q9X
M!N[CPAX_D:.4H58<_B:_5,CG4Q_!\H8>7*Y1L?C7%6'CE7':KXB-X*=S]8?A
M7\(?#'B:T%V+R!B%S7=/\'=,M( L>P@#C KYZ_8[^+TE[ID45Q>;BT8')KZU
MTVY6]TF*Y/(9:_GK-J>;9-5<*U5L_J_@Z7#N?895(4E<X*3X$:5J#BXD$>0<
M]*M6OP>TVPQM"<>U=S%=Q1?(1UITJ+,OR8Z5\^L[KUI<D:FI]E7R*@W9+W3A
MV^"NE7LHG;R\CVINJ_!_PO;1?\3"\@B '5Z[*\O%TFU:ZF/"#FOF#]M;]J.Q
M\&Z(WV*\$3+$<D/7L950SG,<0J=*3?F?+<187ACAVC]:KTXW6I[#-X&^'\5D
MUM%KUH2>V?\ ZU:GPN\(:-HUTSZ?<Q/EB?DK\X?"/[9&JZ_XI@LH]=8A_P"$
M/[U]R?LM>++S7H(Y;BY+[DSR?:O>SSA_,,NP3EB*EV^A\EPGQ-P[G6<)X.@E
M)/='=_'/5+?PQX+N-6CG =,XP?:OS!_:J^,]YXUO9X))6;;*5&6]#7WK^V'X
MFGM? %Y$L^.O?V-?E+XSUZ2_UZ999-V;MAR?]JOK/"[*:U*O]9J>\D?'^/6:
MUIX14HNSL;GP,^%\GQ0^($>CWUJ?*?'S,..37Z'?!S_@GIX/T"UBN46V!V!O
MN=\9]*^<?V)?#^FR^*+6[-JI8[>?QK]*]#,5I91*JX_=#C\*X_$W/L76Q'L:
M<N16#P>X$HRP\<7BO?OJ<?X:^"^F>'84LH?+VIT(%=1:>'+/3V 5UXK3)6=M
MJ#DU4O=.O3*) YP#D\5^+8*&,E4;EB+H_HJFJ6"E[.%'E1?P$@"+V':O)?V@
MOB?#X<\,:CIDMV$WPE<;O>N_UWQI8^&;'S+PCY1SDU\%_MU_'E+S6Y;73+O8
MKR,,!O8U]EPOD4\VS>-.K&\-[^A\!XA\04\IRB=7#5+3>EEYGRK^T#K<&H>+
M-0N%G#;Y2>#7LG[%"^9J-C)Z,M?+GBZYO]6U*>X:<MO;-?5_[#6F21RV4CCI
MMZU_1&?4J^$X?=&.R7Z'\D\'5HU^+56?5_J?IMX7W3^$[%"/^7<5\O?MDW<D
M>A7UH1A2#_6OJ7P;/$_AJR0#D0#-?+_[:T 'A^_D4<X/]:_G?A'"T8<3>UJ*
M[O\ J?V%Q_7=3A&U-]/T/S$URSAM?%-Q+&XR;LDX^M?I-^PG?3+X,ME"G'R<
M_A7YEZU<O_PEURK/G_3#_P"A5^GG[!-LC^ K:8K_ '/Y5^Z^)E18W*HSEM_P
M$?RWX+X7$OBRM&^MOU9]<6RFYM49_P#GF/Y5EW]W+)(;,J=M:]M(B6R*!_ !
M^E59K19)O, %?S11<(S:?0_N#"SG"A.G4U:1^?O_  5.+:3>#RQU=,X_"OF'
M]F[5X1\159I@&^7J?<U]=?\ !4OP?=ZU(TEOG@H>!]*^$?A-]O\ #/Q0)GE.
MU=O!^IK^E^ ZL*_"M:-36T&?PWQQ7IX7Q"J8C%1NE)-7^9^QG[,=\EWHJ[7!
M_<_TKTU8_+G,JU\Z_L9?$&UO-%56<',..M?1-G<I=J)$Z'IBOYQSRC4I9A*=
M*%DV?U_P3F]'-N'(5:.BL3R)]H!9ZI7ES)8#?&/RJW-<)!E2:JW 6]78@KRH
M9A&%94YK<]F&&C.E.I:\C\[?^"B0AU'Q/-<3N PD8X/XU\T?LU7S67CNX,>>
M+H=/H*^A_P#@H_9WEOXSDC1R 9FS^M?/'[-VF3/XSF)ZFY'\A7]0\.*&.X4:
MBOAB?Q+Q3.%/CN2JK>>I^L7[+3"_\#AW/5%ZUZE9:9'&Y/')KRK]E2&2#P6%
M)_@6O6U<QJ,FOYMSM5*>;RBWU/[,X.E#^Q*:IZ*R&SPA#@5"MDLYYJU@.F^B
M'"GI7+B)U%0?(]3U:4)0Q+D9FM6PMK%F0=*_/S_@I[<M-+A\C#1]?PK]"];F
MC:S9",U^>/\ P5,79)E/6/\ I7WWA6ZM3/J?.]?^&/R?Q?4<-D-23ZGRM\#F
MA3Q^C!QGY>/QK]2/V1[ISI**N<>3_2OR>^!LL[_$=%WG'R_SK]8?V,X"VCH7
M&?W/]*_0/%RA*,X2\C\J\$HSEBI2I:>\SW!HS&OF@<U<TR9I8P6':F2;2FP+
M4U@@5.!7X!4:<]=S^MJ*;HWGJRQ1112&5K9RSX-+-;J9-Y[4VU<,_ JQ*NY#
MCK2B9GSQ^W:\(\)$%\8MS_6OP&_;>MHY/BRT@(ZOS^(K]^_VV/#-[K?AMHX7
M;_4$9'XU^+/[6O[+GB77OB"UW$\V,OT4>H]JW@!\N:/';M@,XJ_>V.G"U+B9
M<UZ#:?LE>+(#_K)_^^1_A45U^RIXPED\H3W'TVC_  JY[ >07.S>0ASS5^RL
MXFC#,17J5I^QQXM<[F>X/_ 1_A6C'^R+XICBV;Y_^^1_A60'C6H&*V.$<4RP
MGBFEVN]>QS?L7^,-1;]W)<?@H_PJUI_[ _CJ1@XFN>?]@?X4 >7Q:T^F6;Q6
MAR2N!BN1A/C#Q!K4D%KI4T@)XP:^K_"7_!.'X@:W-&!)=$$_W!_A7TC^S[_P
M2?\ $<.H17>H:;-("1G?$/\ "CFL%CY%_9?_ &4?$_C3Q9I>H7_AR4!9U9F9
M>G%?L'\-?AII?P*^&6F:S+M@<6^YN,8Q7:_L[?L4:-\/;.,WOAN/?&HP6CI?
MV_\ 0IK/X3Q:?HF;=H[9@/*'3K1S!RGY/_\ !2SXU0^)?B(T4=[O1YGR0WUK
MY!EM-/2Z>]BE!9VW&OH#X_?LP>/?'7B'^U1J%TX#DYP/\*X2R_9$\9*_ER3W
M!QQRH_PHY@Y3R32XGU#QE;VH4D,QK]-?^"8G[*VA_$?48%U2!,,P^\F:^4?A
MG^Q!XKN/&%K>-YY ;N@_PK];?^"9_P #[OX<7%M+?0MP0?F&*.8.4]C\*_L$
M^ M-MU8" $?],_\ ZU;UU^R/X/M5")Y73'W/_K5[*D\:G8H IEW ;GE:E2=P
MY3QO_ACGP7+'YS>5G_<JIJO[&G@NXTFZ'[DG[.^!L_V37N:0LL&SO5>5/*@D
MC<?>0CGW%/F#E/P^_P""BW[)UMX-N;_6+"P!4;L,J5^>>GWKZ5<M;W)*?.5Y
M^M?T(?\ !07X 1^-OAS<O:V \Q]_S*O/2OQA^*W[#OC"'59'M6N$ F)^5!Z_
M2GS!RGDFMVNF76D"9)U+D'(KZ:_X)V_&>3P%J.F: +DHDKI&1NKR+3OV1O&A
MQ;2W%PP'8J/\*[7X7?LX^,?!_C;3+M;NX1(KI21@=/RHY@Y3]O;OX8>&OC;\
M$M,6YGCD:6V.01GK7Y*_\%&_V)K?PKXQDN-+TL,L<S'*I]:_4K]B#QE)>>%M
M,\.WT_FF) I#&M;]J[]CS_A;[W-Q9:7N+Y(*IFE=7#E/YQ=:T:^\)7LD,UJR
M"-L<UI:0EAJEB9)91NQT-?H!^U?_ ,$A/'\*7&H6,-U&),L-L0_PKY"\3?L>
M^-/AE=?9M1N+GY3R'4?X4PY3R[47NO#Y,VGQECU^6J2>+-9NY!%-"X!]37;Z
MYX?&G)Y-U'N*C!W"LZ+PLES^^CA 'THO8.4R;:TCNL/<<'KS5]M9GTJT*V.6
M8= IJVWA2ZG(2(L.<<5W7PN_9HU_QMJL5O&TK!^P'_UJ.8.4\<NKSQUXJOXH
MK?1YY%,RC@]LBOOK_@GA^RM>>+-?LKK7-':,-MR76O2_V6?^"6.LZ\T%U<Z3
M))C#<Q?CZ5^AG[/'[(\'PMA@$FCA'CQR4Q1S!RGHGP(^"FA_"72HH=.V#,(!
MVKCJ*[+Q'X7M/$UH;.XQM/J*N3V,FU%AR H XIZW*VT>&'(I7N'*?E/_ ,%8
M?V.H]=\2RZCIFF><$G+95/K7YD?$_P"&/B#P3<2Q+I,BB,G'%?TF?%_X3Z9\
M2+*X:?2TF9T."5S7Y_\ [4O_  3LO]>:YN-/TIT#9QLCH3#E/QFDU;44O4%U
M$R_-SDUT-S/:WNGHGF@G;R#7T5\8/^"<_C'1;UFC2X4*QZ(/\*\DUG]F?Q5X
M2D9KV:<JO9E'^%,.4XVPEL+91#+.%SZU8N=/T>\3*7"$D=JJ:W\)O$-Q> V]
MQ,HSV%7]"^$?B2W8-/=3,/<?_6H Q;L-9/Y< R/:F03SS'#H:ZF3P)=K<""3
M<2?45V?PZ_9HUSQW,(K$2Y+8^510!YK:+<WF+.UB+N>BBO6OV>?V6_%GQ)UB
MUDF\-RNHN5.=N> PKW?X#?\ !*CX@ZUXIMM8F6[>'NIC&.H]J_43]C_]B31?
MA3:0R:]X:C<K'G,L??%%[!:YN?L+?L^V/@+X167GVPBF3'R%<'I7T-+8K?V4
MEI*.&C*_IBJ.DW&F:0PTBQMDB0=$7I6X-BKG'44G(.4^%_\ @HK^QEHWB;P#
M=:U86BRW$F_*JG/2OQ)^.'[.GB[P'JKQIX=E1!,<G;CC-?U!>./#.G^*=).G
M7EDDJG/RL*^-OVI_^"?%E\1HKF?1O#JH6!(,<=-3#E/P/TW21:S>5?+Y;#J&
MK?@U72]-@*I=+G& !7UK\<O^"37Q)TC6KG4;4WD<98E0L8P/TKYE^)O[&WC_
M ,&7NRYO;K"MSN4?X4 <5K?B2YNE,=ME_3!K)BU+5E<*\# 9YYKI](^'E_HM
MSLU L^T\[Q5K4]+M02B0 $],4 8=G80:ZHBO"!V.16K.]KHFE/:6D@+8X J;
MPWX+O;^[(@9@">,"N]\'_LD>+_&^L0FWFN"KG[JJ/\*")JZ/$M-N/%5W?.+7
M3I7!?C!KZ-_9?_98\0_$'Q397U]H$FUNK,F<9(KZ&^"O_!,7Q%+Y%Q=6$S[L
M'YHQ_A7Z*_LH?L5Z;X%TB">]\/H6CV_,R4;"A A_8+_97L/AE:VUPUHL9,8)
MRF.HKZX-I%:67V>'!P>U5K;3=+\/VD4-I9I$40#Y15N(F>/S,\5.YNHGY>_\
M%P-/2;)FX_U77\*_(OQ3#:Q:O(OF"OVH_P""R_PQU'QNI^P%QQ']T?2ORA\3
M_LF^+;W7)#'+/SZ*/\*HYZBM,\FBN[>!"%D%>\?\$\KY8_C4L@<8W1\_B:Y,
M_L6>-I&&V>YZ_P!T?X5[Q^P_^R'XM\-_$Q-0N);C&4ZJ/4^U!K$_;#]EN]%W
MX>#JV?W KT^:[DC8C!KS+]EOPW=Z!H(ANF8GR0/FKU"]B#QG K-]30DMIC+"
M2:\,_;5E \(8#?\ +!N/SKW"QB98"F>2*\<_:S\)7FN^&/*B9O\ 5'I^-$3-
MG\_O[?B&3XH[C_SV>O%;62&-1N?'%?8_[;'[+GB+7/B#Y\)EQYK<A?\ ZU>%
MZE^Q]XNBCRLEP./[H_PK> '$_#=+=_&EM(K@G/\ 45^SO_!'NX NH QP,]_I
M7Y9_"W]D/Q=!XJMKF26X(4]U'J/:OUL_X)@?"G5?"4T'GLX(/<>U35W*B??<
MDT93*M3+:3<>34$5E.J89S^-2)$T!Y-9%%B5MJ;A5?)FY-2R',-1VN"I'L:
M(\C.W/-3Q ;#N]*IEB+DCM5M0?*//:IIJ2@[F=.M[2FWV(9!$&SN%?GW_P %
M*K*&X\1SNS#_ %K=OK7WM/(_G$;CUKX=_P""@GA2\UK79FB9N96Z?C7W'AW5
MIT,Y4Y;:GYMXF.ICN')TH+J?"GPRL;4>-YPSC'G"OUM_8,CCC^'N(SD>2O\
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M/*)2X XTCA:,<-7E:.P_%_@*6845BL+&\U=V1^=WP,_:5\2^!;NVM[CS(P&
M)+U]Z_ G]LC2]=T^VL]5UY4P "'?I7Q5\=_V*O%_@^_:2W>XBV.<;5'^%>66
M-IX^\#WS(?$%T@0],C_"OT7-^&\HXHCS4ZJ=^I^*Y!G_ !5P?&\J4DNQ^QT'
MQV^'TB^8_BB#('K4&K_M&>!K&+,'B:$G'9J_'W4_V@/&FF2F%_%-SUQ]\4W3
MOC3XW\02^3'XHN>N.''^%?-X?P=P.'G[1U?P/>Q/CIQ'/W(T'?U_X)^CGQO_
M &S-/T[1KJ+3=<5VVG 5Z^ OCA\:_$WQDO[G3VCDE3S"HRV:R!X<^('C&Z6
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ML;>);@!3C&X5]]Q'PKE/&$[T)J+\C\9X?X_XGX&G[.K"4HKHV?M%'\8/A_%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
(B@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_0a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0a.jpg
MB5!.1PT*&@H    -24A$4@  !&    "G" 8   !>K"JV    "7!(67,  $SE
M  !,Y0%USO"5  !QEDE$051XVNS8,0$   R#L/HWO:G@2R1PL@,    @-0D
M    6@8,    0,R  0   (@9,      Q P8    @9L      Q P8    @)@!
M P   ! S8     !B!@P   ! S( !    B!DP     #$#!@   "!FP     #$
M#!@   " F $#    $#-@     &(&#    $#,@ $   "(&3      ,0,&
M(&;      ,0,&    ("8 0,    0,V      8@8,    0,R  0   (@9,
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MEB*]!?>U[[8R@Q4&"V? L!C N#WHH73TT(6+7KSUI#=^;UKL7^S2Y73Y(,@
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M&, P@&$ PP"& 8P+'L #QXV7A227AZW$ZH@H)"8>16EIF5<LKLK**FP5@</
M(4/EO7BJ3@;5GJ&Z"ALV1^/ZS9NR13(#& 8P[X>'U;)X,Q5*I>-&2JXEXLP
MD;(OJ$ L09C9<T,1NV^_#/J5X$L.)1S&W- %,C-D^,A1$E![4^V=GAQ+I7L<
M[C<*P2$3Y5J,.W#0Y063&< P@&$ PP"&Q6( PP"& 0P#&,Z&&3P,(_Q&8^FR
M%;(V# 6(S<W-BEY<5+=@4_0618"LH2/]$#0A!$>/'??8N#& 43Z (3A';<NO
M7+N&I<O#?-[O$(0Y=?J,S&;SQ+ZA3"2:U\OIZ?(XCJ_/!P$HZ?^KA?\W&!C
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M;C_B#ASLE5%]$S+Z/#J^0$'(S-ES94<B!C#> V"&CQPENR%1_1PJ7,D QG<
M#-7(B$](D$!C;. XMQTSFCEG'K;OV/7"AW3ZE(3$)%R[?@.E9>50J=7R&"$5
MMR4C"$-9)K=O9^',V7,X$'_H+5]$?FC:C%ENWT/S%BS$\1,ILOTQ7:?#;T(J
M*V7![N@MV^1>9'CB')LR;8;,[LL3>UXC? X#& 8P#& 8P#A#]/V9&C.B"XR(
M$H$[6?AC Q;=UR/X5B/^\[3&J0#F\R,J^9D#KF@Q^Y[^Q7>NSS/*8)".'E"
MYZT@AJ8SK\DBUG,;]I:T8%/^RW$->V2 W\U&_,_9>OSH.'7<J7$J@/GH8#6^
MDZ3"5^E:L;;H>U]^-]D!L4[IVOHB@'F@,XOQ;GWM?C]D\W/T^%U:@\-C_?/4
M.HR_W>C0=W77TL08:=KL#@$'=P 8 GFUK38\:;+BU+,VV36J\YKINVE/$WSY
MN!< YI/X6C'O*GQ^5(T_BS6\_-'+<4FH,$E@Q@#&PP F/")2/%!FB^"W008)
MC8V-O3;J]$/'5@AV9&;>PO:=N^3Q  8PW@-@Z$&X_Z A6+AX*6Z)X)8!C.\
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M4KJ==<=K 0S=QV!Q'W2D*B4U]84?=]123YW&[+FABK@?.A)+1V/3+EQD ,,
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M0_HWI-OB:4D7!:^]TDE+QXY<O?P910+ " #3$?CRW&$5_C-)@_%Y)J34-'*
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MSJD:L;S$BC=/Z3SV50%@.B> ^3WSA0WE=BYVK7$H^VP@$6C*-*.2OZ=C:P6
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MW1@0?EYN;D94B0U_9_[S8H(&W:(%@!$ I@-&7Y_G+5B(%5&KN%%)#'4G"70
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M8 2 $0!& 0"&@E?J O)*DI9W G'G&J23\$5F3\;4!K0]$4/S\-RG'@9@_A\
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M2AC ,(!Q,,CP\!R-"9.G(/C  10)H>,N .:=0>]AZHR9/08PU B&' D+=RB
M(=@U0LSU^$F3<20T#!4:#0.8?@A@&AL;H=<;H-%4RCU045'QU"[$QF+5FK7R
M/ [S&-DO[A^_A0%(O,$ 1M$OEU:KW#>%A86J64%!(70ZG80_#& 8P#" Z?L
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MFOC<[T=6"F&LQ^+T.JS(K._2=MTWXTR9%2GZ)E196^TZIPQ@&, P@&$ XU8
M)OK<>4R<,NW)+].#57G9GN>W$-<3$QG .-C;B&S9BD#%59SZ X"A<!K*9S)L
MA*?<\VJ-M3\!&+I7Z#ZCW$.4ZXD2WY)1XN.CQX[#:ZR/](*AQ-RN F"H]'+D
MZ3,(6+04XR=.5BWA, ,8UP8PE&N,O#':]["SK) \M/8$X8]#1CK,_F^()_XT
MU!/O>([%WD.A>"3N*V>,U6QND.&/SFX,8!C ]$4 DU5CP[3D6ED"_)7P"KO+
M."LQ\JCY;F0E?G=!AQVY)F@L+:@1HK,KJ[.UP=S<:E=X$ ,8!C ,8!C N!^
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M4'V_7ODZ2%,A8(2 $0(F" ,A/'P/&S&*HJ+W44V-L5/2P>%P4,*)$S1QRM2
MS&WYRG<H)R<WJ ]H<DH*O14V)R#VB)PWGRY?N>)V$+KO0 P-'SF:29B77NG?
MY_U\^<I5=.;L.2J\=X_J?1!@/@ZGTTE'C\73N(F3.$!Z\17)/NILO#)@("U:
MLHP.QQZA[)LW.R5\O0'N4T:CD1X4%]..G;MHU-AQ]'+_@;(?G9P+9/"-'#..
M#AP\Y--S(02,$#!"P/0^ H;:LF VWFZ@?U%!XY>4W3TE$-J/T2J Q%O\>GL+
MCP9'"UGXS;WZ3573;.G&5/'9%LYX0=9.RZ-K(/,%09*W<P;Y\M4#&GK^:!6M
MSZ]7WQE8 L8UOJ_L_Z':!UP?>^K+,!NV1V82[(8]T5N=M#:OGOY57?,K:NU/
M=S+GIZ) #F@X\R5-9_O,.14"YK,X7&*A7Y[1>^V/KO%,="LI^/.3.IJ79:(S
M&BOEUMIY'2[?[VA@GSU=J1 P0L ( =/-,?2UD;1XV=NT;_\!RKJ1W6&I#P(:
M0TT-9WW@@6_L^(E"P 0Y 8.LH:O7KM$G6[=1A/I<7\[*0, "$FK#AQOI9DX.
MEPPU-?G^!P DY;GS%VCAXB4T=L(D&C!XJ-QC.@L>E6W6?_"A"M(SJ4*C4?<=
MJT_W ?>Q:K7/9Q(3:<6JU5Q:,WC8:[('CPV4*2Y=OH)B#AZBF[=N^?1<" $C
M!(P0,+V3@,$+]<LJN%Z77T^#56#R#UYFPF!@#0CD5N34\7@OOX%BBBT<O*.4
MPN9E#(P58IT@)U#J],E=\Z-KS,XTT0NGO0]X_^Y0)0U,,M"ZO'I*U=J\MF=W
M"9B_4L'V*Q<-M%KM*;)3$$PW=Y.T<J'4[.#2(1!MR'9:JL[8BQ<,]#>'JNB9
M?1IZJI,YX=__+4%'$6I=-PQ"P 22@ 'Q]:S:FV^I\_B;1#U-NEI+8<K7E]VJ
M>^3['8V3RD9::S-G.;F;+",$C! P0L!T<Z!\)O9('+_YQ,-W2P=W[B:;C1X4
M%3'9\/Z&#U@K0 B8X"9@0)II=3HJN'V;MN_<Q5D9?37@?[G_ .H_:+"RPTZV
M"3)56EI\GY*)P/]Z>CIKS(1%1')6F=QC.LBX&S"(A@X?07M4\*C75RM?=;+M
M? GL+[2:4(YW^,@1+G5"*9_LP9\.E(&A[*BAH8%LZC[ORW,A!(P0,$+ ]$X"
M!L!;<P0H.^^;Z>>GO \>OZ@"QJ_&5-+7#[:.[\55T7 5 +^O@OX4K8T:[-[-
MM;FE]>U^9:.3-MUIH!?4'%W70/;*%Z.]#W1_=%Q'F^^:>?U6)WF=>=)= N;S
M41KV^V\>KJ2W;]7S6ITMY)-,&)!6,Z_7TH\3M/2=(U7TM1@-DR>8:U>!Z \2
M="I8-=+'=\RL1R($3. (F'Y1K1E(R$[ZDCI7T.'Y2W6VL'<NW^]H@)#,-=HY
M\\PI!(P0,$+ ^'<@Y7S>@D6L*Y)]\U:7]C4W-E+:Y<NL=Q(>.=?O;Y(A((N
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MV6RTGL*-[&S:^-$FFJ-L&38GLO4<A+NW%_@[Z/_@L]MW[J*[A85B4(% T&<
M@5;HQ;QZT<#9,#\[I??9F'#%2)ONFBFYJHDTC:%/6*+S$#(U?G5&3[_HCFU.
MZGC\[[EJVGG/3!9'BSBB0!!B$ )&(.ACP)M79$'DYN911D86I:9=YG*YY)04
M3HWO;.!ODMK^!B4>EU+3.(,M5$1T@P7(,"@K+^>,J_2,#+;EDVS_I_OPQ_W
M9Z^G9U!)R4,N:?"T9;V .!L!;;<OI::V^G@[&[NS#ZUG(97UEU#*(A (!'T%
MT/))K[91?)F5#C^TT+ZB1I^-1(V5,QM0%M!@#_T7"]"I08E,3'$CE]]UQS9H
M)1U;TDAY1KO;^A\"@4 (&(% (! (! *!0" 0" 2"/@,A8 0"@4 @$ @$ H%
M(! (_ PA8 0"@4 @$ @$ H% (! (_ PA8 0"@4 @$ @$ H% (! (_ PA8 0"
M@4 @$ @$ H% (! (_ PA8 0"@4 @$ @$ H% (! (_ PA8 0"@4 @$ @$ H%
M(! (_ PA8 0"@4 @$ @$ H% (! (_ PA8 0"@4 @$ @$ H% (! (_ PA8 0"
M@4 @$ @$ H% (! (_ PA8 0"@4 @$ @$ H% (! (_ PA8 0"06#P_P   /__
M[=@Q 0  "( P^Y?6%%QN$3C9!0  >&LD     &@9,      Q P8    @9L
M    Q P8    @)@! P   ! S8     !B!@P   ! S( !    B!DP     #$#
M!@   "!FP     #$#!@   " F $#    $#-@     &(&#    $#,@ $   "(
I&3      ,0,&    (&;      ,0.'KULZE#AP1      245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document<br></strong></div></th>
<th class="th"><div>Mar. 19, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 19,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Bausch Health Companies Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">A1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-14956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0448205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2150 St. Elz&#233;ar Blvd. West<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Laval<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">QC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">H7L 4A8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">744-6792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares, No Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BHC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( !U?<UI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( !U?<UK&-<9\[P   "L"   1
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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M! 7W_D4%Y7MJZ&B@Y(XH^S2HV9/B4XMH@./"CLK"*+C+(<Z,WLLHATXV ]>
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M[G[VH%5TSCTJ]QY>R593RNF'5C]02P,$%     @ '5]S6B0>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( !U?<UIED'F2&0$
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M;W!S+V%P<"YX;6Q02P$"% ,4    "  =7W-:QC7&?.\    K @  $0
M        @ '#    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  =7W-:
MF5R<(Q &  "<)P  $P              @ 'A 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( !U?<UH(0>NV6@0  !,1   8              "
M@2((  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  =7W-:
MGZ ;\+$"  #B#   #0              @ &R#   >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( !U?<UJ7BKL<P    !,"   +              "  8X/  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( !U?<UK)@?M/,0$  "4"   /
M      "  7<0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  =7W-:)!Z;
MHJT   #X 0  &@              @ '5$0  >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    "  =7W-:99!YDAD!  #/ P  $P
M    @ &Z$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   $
%%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bhc-20250319.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bauschhealth.com/role/Document</Role>
      <ShortName>Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="bhc-20250319.htm">bhc-20250319.htm</File>
    <File>bhc-20250319.xsd</File>
    <File>bhc-20250319_lab.xml</File>
    <File>bhc-20250319_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "bhc-20250319.htm": {
   "nsprefix": "bhc",
   "nsuri": "http://www.bauschhealth.com/20250319",
   "dts": {
    "inline": {
     "local": [
      "bhc-20250319.htm"
     ]
    },
    "schema": {
     "local": [
      "bhc-20250319.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "bhc-20250319_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bhc-20250319_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://www.bauschhealth.com/role/Document",
     "longName": "0000001 - Document - Document",
     "shortName": "Document",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bhc-20250319.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bhc-20250319.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Country",
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.bauschhealth.com/role/Document"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000885590-25-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000885590-25-000010-xbrl.zip
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M%_ DDC9(--[3 ()F<LJH#6G^P)T#,JBL9XY1R\H>V2-MS2?+P?">@G%![*7
M15@3R@E?, ,C?9-8#K%\3L <@;QYQ?(6ZI3O+D0 FH?E\T:X[7:MK7<W#7#U
M;JW1[3X8X);]7JOI[<Z&;^0#I<%4G>8W/!50O=U^F+IA6E&40T0Y@KZXQRPA
M*7^BWK8F+^YBYP9Q3>_4IY@CL"ZN!]9>U,E&/OB#@1LXOK<<N&;:9V+9K<?,
M*?46GGMKR%$K?]D$"X;A!4?;90?SL44+/:9O/H'0-IOL$9VKWQ(RFPI-WS0]
MQGDH*>M2$@H'OK82D!;$VM2A9GFQ."I#26G_7R\M/UHV@\%C\&$AH8ZP.J8I
M6K/;.MJN"KUV6MW0^[.P2F@(@Y4F7+MRTNTH:K/9@3S\0<KEFOON?I-P+0 6
M)#P0-INX'G']&?/(GY#C<=.262 $7E;2OA^^5E4KP!V"Y+G%<3N-3$"-B"/$
MH1C+/5>2 BS/KD=D.%_8[A+XFY9_<N'6#M<EN[!XF0BC<[%^?COPI!PJ]#_A
M_\YA/BVR 9W*B:ZU5#+R:V1H__NG'_5&XYAZY+U]:];([Y#C9@U#=8.Z5]K]
MP9^7WHU[%[NX;N7DG-Y2>VM+".6^]*X@X++$=EW6TW(<@/%8VM=J:N7D'X%$
M?LR,[:&\D<?7M"*7_]3UKUQ V/Y_:R&CTW 9O7)RVCXGS7YGOVLTY4H:!R&N
M:+VO/&"[M: V&=XS(_"M6T8N)Z#]C!^2 Z #04+L4YFFH!I0GM^H57V/T12'
M&Y63EM;,<O=P S$Z=\&67\U<)Q-L:9"WM)M-Y:C=U<M76?99?%8%IC><^,QF
M"\0Z](U5# CL 'T?H4!E(-EKD)^+>G^/8"P@_$>PB>"A9<G+$R82/E*IS4#X
M"9%5=Y-P-.;$ICPJM>X3!\H46F,P7P:8P8P97T0G%%V \UMX%L; 8_>>C)GM
MWB&I\2$RA'24WS X1(&W.$B_SQP36."[P(5Y8/O486[ [27A$%'QR5*\&;[@
MCH'P- JE\4&BCAG /,!>9QD]F[@V+([OH4.V,"SEO3VA6 '[,N&P@F4)N64H
MY,YR,-KL*?A->;GK SML\MFQT+:03Z.O@[R\B?_=LWS@+B8%@1,&R#R][3.Q
M[IFIB*Z;V &TD#I=\ ''1='#5AG6V(!?3_OO;G9#RG$KY &P*<D$LDAL45X'
M-I. -O56J$5^>G\2MR4/M#89?+PF>D.MP<!U"_E=D7:E2"/7M@S@A#/]!'85
M@5@/^,>N:X\I&#P?S&ZL2T??=6E[HK9B YF'?"A0)*U)(0M*Z%)J@S_6I*9:
MDR._*]/S*=.5Q] C86^EZ)C!\,.#' Y3D')*U?ZN5-L3.6"'8B3X4<Y3:4U3
MT0_&A_)3*3V3+WS7M!?3M#/. ^8]0=\ZWXZ^D0<@_HJ^M-VH&M$:3&D>&(>E
M'%DXMCAS+B_3>5W5+Z:IB3!8)IO,@W1UD=?CAP8F2CZ!/KU'ZU7[TS[SQ 9Q
MO5T[:K2VTU]R!$9ZTY:; JA:M:ZVQ:D:7].J$K).2OU:LWOX--P *NB$+[TI
M)EGZ0OMB-WA,2#8O&C-BV)3S$AM__SWD\:BH\HZ6\[%K'_ R>[^EB./)1;YE
MVEV$78M"LECD@L#DWLTL^&9EEQ]O*B@ZAU)(OV>1S+EEFC;;^ZZ/T!<N-7TL
MM#T.T;J5$PSU@".C&?48KY(+EUQ1C_R3VD'.@;JR9N$[<\HS)S0PTK[$7?-J
MY>3]Z> [!YY3/:(@63:4K[5LPM/TOKRN@8D#8/_/];Z0D>\:7^(X>W>,>QZW
M\:*<NW$]&..ND?31]IR7R33.'!-S,4;&2V*('34(Y+^ CV.BDRRSW65Q B!"
M(H>Q_I1,/??.GV%*M\ M,,J)R2:PA&CI%]E<4VU%R4FFM"]/'#7( 2:I[6-1
MX8\&6^(PP (/ ^ FJLP+];&BY\R5=XPIGA1SQ-5[B6EK&VWK)S*GHYS&[Q?:
MC1T6L '_;5BD>&JU9CN=7!$BOP@\Y*&7G/:BW$*-KC]OH:8D;];%ZX74>_*
MPF(?2*[V6VO[W#/0;68S V\@<5Q1@0@X$Z. M>%N.EZW88FJA#Q CQP4:]E+
M7%S<7(("Z@!N\,1CMQ:']\!B4,=  :2&:"'#P7@UA4D]D\M]=+.H_-$XH''Y
M(VD*:F1+A>?MJD8LJB\GFE]3M,^CXR-UIM=257H-UPXD[X98N%+7>AZS*?8$
MKMT6L0)"K*ZN7J%C "/PBU\I:CAZL$A:?"_%II=CM./+,68QM1=TRI2QQ^@7
MA4X HAZU[^B2(]%V<X,&^AP%Z.!1P^_Q8 ZBN#Q.U9.;K6P]N=G:9(^DI%IK
MCUD634=+[[,YZ=14C5R*R&V(AWCY;@Q-%J(U0R,@*O*!!4*4'W\=K85?NZ.O
MF+%G^2#X1MDB/?BE"]>'9<3N$GJN)R.6$B6]67L.6<K'[-(AZ6/O5?+0P61R
M@-[WIQ\[NJX>A^&;^*0='T+*P ,@$@4_COW,8*T8A<B!.@ZX>@,)YL^H+PX
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M>N241+["J,C["$31&3DS WK(&NZ*HF3J@MEQY'9)4FND**<K9.LR7(W%<+5
M.+"04:][L_D%-XY?+@YX4)R3I5@:61<0TC^QCAJJ]F,F;;5OM9%9$Q)_)^I
M8&F8YU.P3O*J.B/@0"54DM@";2NZWNOZGNDROE:K2X04CVFTT'O@H@&HC;$.
M0S!-\:CXA1@1GX?\#&F*$;S!D"X1KQ,K1/G.RN8+[[P>H8B!K@%IT[<2E.^3
MQ.PN(RM3?M\@(\MQ[\]ZB/+1CAC9^X@=,=V:JM5V(ZSE[D#?M!5WJR3X&+=6
MBNJQK%NBZ0YE(\?4[A<C12,1_GY%!'"YD[YM/=N9A=\\'%?DM"_B>>'4O%BP
MB;^1AQD:F8[P\$A"WN+/VP?9!6/6W+@-4FO7.MVCK5Q.K]<:G8=/L98%JMVN
M-?1=W=W^7+=P/VHNA*Q'1EM>4+C!);9Q"^DK)\ '!KFI)<*-C0Y64N/+U',A
M&E5"2 V#L<FD^&C10^>*\DBRH\.HCP8'(@5!'_YSF7-8160H*2;/2,:M9$R3
MR<Y. $M$3&:$]V;WQ!X"C@)P:&Z7,)/*>_SB )+5#SV*?D6YJR5"1ADQUF;^
MO*B#]6V=/G9VYFNQ*A_>[PTCM@5R2=:09^#"WM-\IQ2^$@G4=9A F2+7R?[8
M%\W6>I[DB2;BWVOS-_K3_$T&V8W]S5<2ZZ$DY;N^/*8O6-K'_?ZTRDA]6=N
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M6D?M;>QP[_\^<+E[%-_W/X\&I^1TV#^_.26#RT]7_8NSX8B<70QJ>1O#F4A
M:SYP+=.&M$K?SO2L2[TB-N9'^-(4O%_V-FAEV >D-MKNJYS4>9W\.NQ?*+_V
M!__X#&(Z..U?GUY>;-+"4#8I?.)=J0\FAB\C'+\RZBB_4N.O .8<S*@W2S1]
ME*XYO%[+ET^5U:^\_A.;@;%$8Z%'KP*)+#8AJZ8^^2NPW@Z$[-40ZV#UZ[AK
M=-GD1[%WGD"6RP3K8]=<PO]F_MP^^0]02P,$%     @ '5]S6M:]4I9? @
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MEBVO=92LCC*(ZRC_V@<V&1#^"\5;[<;Z L$U=#^_5(S[<OKYQ<*],G<(=?R
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M:AW%U#2 I@NL%8K-9P$)K:6XZ7BL5<(:RWUIL*%NOR+H2LAS(7 O%Z_5O\W
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MXV@I)]%M?+^&?(DH_S<W-^T*%[<K7]\MD5[F$%LBBH"%,(V!6$XMH1IX< F
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MDTXA<0-#B41!FM*4PWD-ZE821[>@ZE:GOJ='1SBHC!R'R5SPV-P 9DM^U0F
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MC+DJE04S;FFHJ&K\Y8BF?8SA+W-GFAP84 4BNR1V#?7:<2@X9%7E.J5ZE_)
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MI@RAF@[H(\:'G_@TP_^<<F\JA@0J]AJI"^P"N<L[:]R-;(ALDG[?(EV!.GX
MWL0W39&$VX&A9OCIK/S_1E<CY&?D6MR:AWD4T"7()X'KYP:2Y!I]X#92JN!9
MQQ1%![242E:Q+'H5"<QD6^YL'XQW6@,*%Z<X.V_WX2+E(L[X9'\7"L>>E$R+
M/B&/I+G>!4J'&**HKHD'Y' D';'DI&D#"DCQ-"@=M I6Y9>',-U^2;-@LPR\
M/(3ZBLX89A20@ZTGP7*=+%2KUU7W<-80RVXT8V"C/Z'993K22AX&J?4L3#Q8
M$\F&L>>F*3*:K:D*.0?)"'E;( E3S96 V#]"(Y8N5_CJR-76WUDXFIHE?(+;
MO#FQOT@,XDBO+O/T1/^08M*]1Y*]$TD^D-14G9P6)I'%(%8IH_W/I"U!.QHN
MJ2Y/7E1E04S(!11<,FX/=:BL2+91^8+,)+.Q#)PIZF<!,8_H(L(%'X0R2Y5@
MCU&)2OVHT.]6%:;FZG8#2D.5J!B?.7A*P0<&A"XP@ZQ)/5FD1JLNF"!/)54]
M^0 >NIZ"#LW G7W\7*FF?0S<ELOG5"\GE..CA->:*:S619I0R9C;]541">-"
MQ<4,>CI Z(4811'* O?5)RXC.^.SU3_C-5DF>GDD8,+94MB5(F2QTW#6%:9D
M]<4=P?06SIL*X1"+JOTAV-5T80\T=""^O7R'GZJL"[-0;94_WFZ%\K^!;9>(
MBG@& EFR4 .!H(D(T<)_ Y3W=@_&^>2C7B";S^>C]7MB#XGX;[,VTF!,X4/^
MWA"=^OC*VGKYQ';HC:YN5/;=0ZKXMVW*4R1JF^,,+&XN;39\8\P-^8DKBI)$
MF)S8$(+^(PA__FQ\N/L$#X0>X&>5FJ_H62DY.?-2\VD#J[N(ZG8K=6]FMK*N
M097"'X3TR4TWYV3N(W.$ 6F1ZE-8(J?)J55@;$S(WR$2$DV[6HWT!K^F@4;]
MH,CGK@CRR0$[Y/ODI67%#!]Q 5%"<P#C@!UKS52%B///C<V<>/YL;_^,TL(!
M?PK?5UF?ZSZ>F;K_(%R1Z3V*-=7NH[K YG4?N!GQRNZ3=/W!?/T!UM;]FH X
M@!/TAUWFU.%AB'A6RYC1@M0B<2VDI7H.T75ZS)4:I[IJI/!9*<VL&=!!'&2.
M0[3#,15?)MB\EWG#;*16E@,D'H<4/Y&46#9US*3;2D#0F5QE^KR4G(?JG-US
M#:%?*$B59<2"Q]^$5^FJ%S\+)VN4[;,FP:"XW 2>)(MX@8"90Z8YS:#<WX:3
MEE!]FE%NFRF76IV$&C2)?+]IC$ =^?1=IPT4.N@5&=)E.K.Y&.' O&+BL-T[
MS#%TJ8". MO$9NVLDZL7)H4FN3S1*4<HLGK'Y_IU^%NM6.-I95J6*D+5@NIP
M2\$DJX;HF4S"Y:AE58:HX=30C0+.I.C:C_KPM)G.,N4M B$+U(K;D0-I&*/L
M3HF&&%Y<A4EXTZDI7%U[[*K9,N-[Y/PA:,*UF@)$-->$B#FV1[$Q6^-K$'P:
MV[D:0G<YXL6;BS[0UG ;I'D0M:'V&H@F7^4H>!-ZD>Y+:(\OJ4 ]])>;O(2N
MPZ6]X1&H&K[HPWE]I-)0E4^EP=0JDIY$BW<H^%R;[E\$@3,^QMU8JMTP=%AN
MKHGDN]4!#KO[CING@5^_3V><M_"=!79(;44OU)<T3*GSSD56ZBJDW7P^&,K
MY)CH/H]DEMZY^D9)/@1,:#4P1P6]CQ!3))> .$F0#6TS71\PO%6AE S*UM"]
MHT*S?9BJ7R=\R"U</])#N%K)&PQ)A[S+4)C1YI.T)N]7SID\>GFCR/'"%(HV
M,M*179W=*6&V$__W:.SS.1K; #*N3^4%7P:X#6EN)WUE3ZYMVI1TXX"B."M]
MA<3V,EZ/,[9EKS!L#*UMD6) %;)0 /RYT?%L'Y3PT>)6^W<"]ZO_B8+W1?AK
M]Q?\5_;_ %!+ 0(4 Q0    ( !U?<UHCXB+M2A<  "R8   0
M  "  0    !B:&,M,C R-3 S,3DN:'1M4$L! A0#%     @ '5]S6M:]4I9?
M @  "P<  !               ( !>!<  &)H8RTR,#(U,#,Q.2YX<V102P$"
M% ,4    "  =7W-:-%QWPH,*  #:6   %               @ $%&@  8FAC
M+3(P,C4P,S$Y7VQA8BYX;6Q02P$"% ,4    "  =7W-:-;$@>-P&  #Y,@
M%               @ &Z)   8FAC+3(P,C4P,S$Y7W!R92YX;6Q02P$"% ,4
M    "  =7W-:2DWY&LT.   (.P  '@              @ '(*P  8FAC+6YO
M=&5S;&%U;F-H<')E<W-R96QE87,N:'1M4$L! A0#%     @ '5]S6N01R@F"
M#P  ;#\  !X              ( !T3H  &)H8RUT97)M;&]A;FQA=6YC:'!R
@97-S<F5L+FAT;5!+!08     !@ & )@!  "/2@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>bhc-20250319_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bhc-20250319.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885590</identifier>
        </entity>
        <period>
            <startDate>2025-03-19</startDate>
            <endDate>2025-03-19</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-23">0000885590</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-24">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-03-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Bausch Health Companies Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">A1</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressCountry contextRef="c-1" id="f-5">CA</dei:EntityAddressCountry>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-14956</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-7">98-0448205</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-8">2150 St. Elz&#xe9;ar Blvd. West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Laval</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">QC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry contextRef="c-1" id="f-11">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">H7L 4A8</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">514</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">744-6792</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-19">Common Shares, No Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-20">BHC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-21">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
